PRKN and Parkinson disease: demonstrated that enhancing PINK1/Parkin‐mediated mitophagy in Parkinson's disease can reduce mtDNA in the cytoplasm by clearing damaged mitochondria, thereby alleviating cGAS‐STING‐induced inflammatory responses and reducing nerve damage and disease progression.